By proceeding, you agree to our Terms of Use and Privacy Policy.
As a leader in eye care for over 70 years, Allergan, an AbbVie company, has discovered, developed, and delivered innovative therapeutic products. We have launched over 125 eye care products and invested billions of dollars in new treatments for the most prevalent eye conditions including glaucoma, ocular surface disease, and retinal diseases such as diabetic macular edema and retinal vein occlusion. With a steadfast dedication to eye care, our team provides support for continuing education programs, eye care teaching institutions, educational initiatives for recent graduates, practice management programs, and a dedicated sales force.
18-20 August 2023
This two-and-a-half-day symposium is intended to provide ophthalmologists with an update on the diagnosis and management of vitreoretinal diseases. Emphasis will be placed on conditions that have seen recent new developments. Didactic lectures and vi
Event Ended
USA
Paid
Chicago